RenovoRx Inc. (RNXT)

AI Score

Unlock

0.95

-0.05 (-5.00%)

At close: Apr 03, 2025, 3:59 PM

0.95

0.81%

After-hours: Apr 03, 2025, 05:29 PM EDT

Dividends

No dividend history available for RenovoRx Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield

Dividend Rankings

RNXT News

3 days ago · RenovoRx Reports Initial Revenues from RenovoCath® Commercialization, and Provides Update on Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial - businesswire.com
1 week ago · RenovoRx Highlights New Human Pharmacokinetic Data Abstract at SSO 2025 Annual Meeting - businesswire.com
1 week ago · RenovoRx Pre-Clinical Results Supporting TAMP™ as a Targeted Locoregional Drug Delivery Platform to Receive Award at SIR 2025 Annual Scientific Meeting - businesswire.com
2 weeks ago · RenovoRx Announces Abstract Presentation at the Society of Surgical Oncology (SSO) 2025 - businesswire.com
1 month ago · RenovoRx Announces Pricing of $12.1 Million Underwritten Public Offering of Common Stock - businesswire.com
1 month ago · RenovoRx Announces Proposed Public Offering - businesswire.com
1 month ago · RenovoRx: From Clinical Promise To Commercial Reality And Trading At A Significant Discount - seekingalpha.com
2 months ago · RenovoRx Announces Acceptance of Abstract for Presentation at ASCO Gastrointestinal Cancers Symposium 2025 - businesswire.com